por
Becky Jacoby, Reporter | February 25, 2009
Despite economy, health tech
projections remain favorable
Recession predictions seem removed from impact on some sectors within the health care industry. Here is a summary of new projections from Global Industry Analysts, Inc (GIA) for the year 2015.
PACS market headed for $4.8 billion
Steady growth would be welcome news for radiologic Picture Archiving and Communication Systems (PACS) technologies. As expected, the U.S. leads the market in leveraging computers and data communication modalities, driven by technological advancements particularly in accommodating image volumes. European market growth of PACS is still struggling with the balance of quality in patient care and reduction in cost. It is reported that software licensing represents the largest component.
Key players are GE Healthcare, Philips Medical Systems, Siemens Medical Solutions, Carestream Health and Fujifilm Medical Systems USA.
Hospital Information Systems (HIS) market passes $35 billion
The HIS market includes two segments: non-clinical and clinical information systems. In the non-clinical segment, the proliferation of Health 2.0 flings IT services to the forefront of daily operations. Though the U.S. HIS market remains the largest, global governments are adopting new standards and demanding customized solutions. Asia-Pacific is expanding in HIS keeping pace with Australia. Growth of clinical HIS is particularly strong in China, India and the Philippines where the climate is broadening to include more emphasis on drug trial partnerships.
Market leaders include McKesson, Cerner, Siemens Medical Solutions, GE Healthcare, and Allscripts-Misys Healthcare Solutions. The full report highlights recent merger and acquisition activity.
Endoscopy Systems market may reach $4.5 billion
As techniques and procedures change and become more refined with the use of heightened biotechnologies, robotics and imaging, the endoscopy systems segment is projected to grow significantly. An aging population demanding both preventive and minimally-invasive care will drive the market. Look for growth particularly in visualization equipment such as high-definition camera systems and video processing. Novel products such as cancer screenings will impact this market.
Dominant in this market are the U.S., Japan and Europe. Leaders are Boston Scientific Corporation, Conmed Corporation, Ethicon Endo-Surgery, Inc. and Medtronic Neurologic Technologies.
Ventricular Assist Devices (VAD) market headed for $1.2 billion
Capitalizing on the needs of an aging population and a demand for heart transplantation, VADs are emerging as an ideal alternative form of treatment for end-stage heart failure. The devices are becoming classified as next generation and expected to be adopted across a broader patient population with the proposal of destination therapy.